Ruiyang (Suzhou) Biotechnology Co., Ltd. is dedicated to the research and development, production, and sales of biopharmaceuticals, including novel therapeutic antibody drugs and recombinant protein drugs, and provides technical consulting, technology transfer, and technical services.
The company has established comprehensive laboratory facilities and a talent team. Its mammalian cell production process technology platform consists of a self-developed antibody molecule screening platform, a fermenter and process scale-up technology platform, and large-scale single-use cell culture/traditional stainless steel fermenter culture technology, with excellent equipment and advanced technology.
The company is located in the Suzhou BioBay, where Chinese biopharmaceutical companies are clustered. The core members of the company's team all have more than 20 years of R&D, production, and management experience in the biopharmaceutical industry and multinational pharmaceutical enterprises, and have led the development and application of multiple recombinant protein drugs and antibody drugs. Its partner Ruiyang Pharmaceutical, founded in 1966, has total assets of more than 6 billion yuan and has ranked among China's top 30 pharmaceutical industrial enterprises for more than ten consecutive years. It has a well-established sales network and a professional marketing team, and its products are exported to more than 50 countries and regions, including Germany, France, and South Korea.
The team's advanced technology and rich experience in biopharmaceutical development, combined with the strong financial support from Ruiyang Pharmaceutical, have laid a solid foundation for the future development of Ruiyang (Suzhou) Biotechnology Co., Ltd.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows